Scientific Advisory Board
Scientific Advisory Board
August 1, 2008
Retrovirox Inc. announces the appointment of its Scientific Advisory Board (SAB). The SAB is comprised of seven members from prestigious academic institutions and Biotechnology companies. The SAB appointees include Dr. García-Sastre (Mount Sinai), Dr. Saunders and Dr. García-Guzman (Vertex Pharmaceuticals), Dr. Gallay (Scripps Research Institute), Dr. Planelles (Univ. Utah), Dr. Guatellli (UCSD), and Dr. Madan (Neurocrine Biosciences). Additional information on the members of the SAB can be found in this link.
This outstanding team of internationally recognized experts in the fields of Virology and Drug Discovery will contribute an invaluable wealth of experience and expertise towards a solid development plan for the company's portfolio. The group will provide critical scientific and medical input on the company's strategic directions, and will play an integral role as we advance our product candidates through pre-clinical and clinical development.
We are very fortunate to have assembled such a distinguished group of scientists. More members will be added in the near future to augment the strengths of the SAB.